Designed for patients and urologists who want a better option for treating BPH.
Aquablation therapy is a unique, next-generation BPH treatment that is changing the tradeoff between symptom relief and side effects. Patients can get significant symptom relief with less risk of side effects that impact their quality of life compared to the surgical gold-standard TURP.
A Synergistic Solution
The Clarity of Real-time, Multi-dimensional Imaging
In addition to a traditional cystoscopic camera, Aquablation therapy includes intraoperative ultrasound. Together, they provide the surgeon with a multi-dimensional view of the treatment area, enabling improved decision-making and treatment planning.
The Accuracy of an Autonomous Robot
The surgeon maps the exact treatment contour, and then monitors with confidence as the robot autonomously executes the treatment plan, guiding the precisely calibrated waterjet with speed and accuracy.
The Power of a
Heat-free Waterjet
Harnessing the unique power of water and pulsating near the speed of sound, Aquablation therapy removes prostatic tissue with a heat-free waterjet, eliminating the possibility of complications arising from thermal injury.
AquaBeam System
Aquablation therapy is delivered by the AquaBeam System, the world’s first autonomous tissue removal robot for the treatment of BPH.
The intuitive design coupled with robotic execution allows for a short learning curve, short resection times and consistent, reproducible results.
AquaBeam System
Aquablation therapy is delivered by the AquaBeam System, the world’s first autonomous tissue removal robot for the treatment of BPH.
The intuitive design coupled with robotic execution allows for a short learning curve, short resection times and consistent, reproducible results.
Proven Results
Backed by a global clinical trial, Aquablation therapy has demonstrated a superior safety profile when compared to transurethral resection of the prostate (TURP), the surgical gold standard.
Predictable Precision
The world’s first autonomous tissue removal robot for the treatment of BPH, offering the peace of mind that comes with consistency and precision.
FAQs
What is Aquablation therapy?
Aquablation therapy is a minimally invasive, heat-free surgical technique to treat benign prostatic hyperplasia (BPH).
How does Aquablation therapy work?
Aquablation therapy is delivered by the AquaBeam System, the world’s first commercially available autonomous tissue removal robot for the treatment of BPH. Aquablation therapy combines multi-dimensional imaging and autonomous robotics to deliver a heat-free waterjet to remove the enlarged prostate tissue with less risk of side effects that impact the quality of life than the surgical gold-standard TURP.
Who is an appropriate candidate for Aquablation therapy?
Aquablation therapy has been proven a safe and effective treatment for BPH patients suffering from urinary symptoms. You should consult with your urologist to review all your options for your condition.
What happens during an Aquablation treatment?
Aquablation therapy is performed in the operating room, while the patient is either under spinal or general anesthesia. During the procedure, the urologist will use multi-dimensional imaging to identify the exact treatment plan based on the patient’s specific anatomy. Next, the AquaBeam System robot autonomously executes the treatment plan, removing the excess prostate tissue with a heat-free waterjet, eliminating the possibility of complications arising from thermal injury. The procedure takes less than an hour, and typically involves an overnight stay.
What happens immediately after the Aquablation therapy?
Patients may go home with a urinary catheter. For a few days, the patient may experience a slight burning during urination as well as rectal soreness. This can be managed with mild pain medication. Patients can resume their normal activities at the discretion of their physician.
What are your clinical results?
Backed by a global clinical trial, Aquablation therapy has demonstrated a significant reduction in sexual side effects when compared to transurethral resection of the prostate (TURP), the surgical gold standard. SEE THE DETAILS
What are the risks associated with Aquablation therapy?
Most side effects typically resolve within two to four weeks after the procedure. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder and bladder or urinary tract infection. Other risks include anejaculation (10 %)* and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. For more information about potential side effects and risks associated with Aquablation therapy, speak with your urologist or surgeon.
*Gilling P. et al. “WATER – A Double-Blind Randomized Controlled Trial of Aquablation vs. TURP” J Urol. January 2018.
BPH Education Center
What is BPH?
